Opzelura ruxolitinib cream 1.5 price?

Opzelura (ruxolitinib) cream 1.5 % is a prescription topical medication used primarily for mild-to-moderate atopic dermatitis in adults and children ≥ 12 years old. Because it’s a specialty drug, the price can vary widely depending on several factors:

| Factor | Typical impact |
|--------|----------------|
| Manufacturer’s list price | Roughly $2 000–$3 000 for a 60‑gram tube (about a 3‑month supply) in the United States. |
| Insurance coverage | Many commercial plans cover it, but patients often pay a copay or coinsurance that can range from $50 to $1 500 per prescription, depending on the plan tier. |
| Manufacturer assistance programs | GSK (the manufacturer) offers a patient assistance program (the “Opzelura Assistance Program”) for eligible patients who cannot afford the drug. |
| Retail pharmacy vs. mail‑order | Prices can differ by a few dollars; sometimes mail‑order or specialty pharmacies have slightly lower out‑of‑pocket costs. |
| State Medicaid programs | Medicaid coverage and costs vary by state; many states reimburse close to the manufacturer’s list price, but copays are often minimal or none. |

How to find your exact cost

1. Ask your prescribing clinician – They can check your insurance’s formulary and give you an estimate of what you’ll pay out of pocket.
2. Call your insurance’s pharmacy benefits manager (PBM) – They can confirm copay tiers and whether the drug is in‑network.
3. Visit the GSK Opzelura Assistance Program page – If you’re uninsured or underinsured, you may qualify for a discount or free medication.
4. Check online pharmacy pricing tools – Some third‑party sites allow you to enter your insurance and see a personalized cost estimate.

Typical out‑of‑pocket ranges (based on recent data)

- Commercial insurance (high‑deductible plans): $200–$800 per prescription.
- Commercial insurance (low‑deductible plans): $20–$60 per prescription.
- Medicare Part D (if covered): $30–$200 per prescription.
- Uninsured: $1 200–$2 500 per 60‑gram tube (before assistance).

Note: These numbers are approximate and can shift with changes in formulary status, new pricing negotiations, or updates to assistance programs. Always double‑check with your insurer and pharmacist before starting therapy.

If you need help navigating the assistance program or comparing pharmacy options, let me know!